€5.21
2.16%
Madrid, Dec 24, 02:00 pm CET
ISIN
ES0134950F36
Symbol
FAE

Faes Farma SAReg Target price 2025 - Analyst rating & recommendation

Faes Farma SAReg Classifications & Recommendation:

Buy
67%
Hold
33%

Faes Farma SAReg Price Target

Target Price €5.61
Price €5.21
Potential
Number of Estimates 6
6 Analysts have issued a price target Faes Farma SAReg 2026 . The average Faes Farma SAReg target price is €5.61. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 6 Analysts recommend Faes Farma SAReg to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Faes Farma SAReg stock has an average upside potential 2026 of . Most analysts recommend the Faes Farma SAReg stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million € 493.65 568.13
9.42% 15.09%
EBITDA Margin 26.10% 21.90%
3.66% 16.10%

5 Analysts have issued a sales forecast Faes Farma SAReg 2025 . The average Faes Farma SAReg sales estimate is

€568m
Unlock
. This is
0.00% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€595m 4.79%
Unlock
, the lowest is
€547m 3.74%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €494m 9.42%
2025
€568m 15.09%
Unlock
2026
€661m 16.43%
Unlock
2027
€743m 12.28%
Unlock
2028
€776m 4.52%
Unlock
2029
€733m 5.62%
Unlock
2030
€787m 7.38%
Unlock

6 Analysts have issued an Faes Farma SAReg EBITDA forecast 2025. The average Faes Farma SAReg EBITDA estimate is

€124m
Unlock
. This is
1.06% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€133m 6.04%
Unlock
, the lowest is
€117m 7.27%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €129m 5.41%
2025
€124m 3.43%
Unlock
2026
€156m 25.70%
Unlock
2027
€179m 14.72%
Unlock
2028
€190m 6.06%
Unlock
2029
€204m 7.18%
Unlock
2030
€221m 8.29%
Unlock

EBITDA Margin

2024 26.10% 3.66%
2025
21.90% 16.10%
Unlock
2026
23.65% 7.99%
Unlock
2027
24.16% 2.16%
Unlock
2028
24.52% 1.49%
Unlock
2029
27.84% 13.54%
Unlock
2030
28.08% 0.86%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 0.36 0.24
20.00% 33.33%
P/E 21.49

5 Analysts have issued a Faes Farma SAReg forecast for earnings per share. The average Faes Farma SAReg EPS is

€0.24
Unlock
. This is
29.41% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€0.28 17.65%
Unlock
, the lowest is
€0.21 38.24%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €0.36 20.00%
2025
€0.24 33.33%
Unlock
2026
€0.33 37.50%
Unlock
2027
€0.37 12.12%
Unlock
2028
€0.38 2.70%
Unlock
2029
€0.39 2.63%
Unlock
2030
€0.43 10.26%
Unlock

P/E ratio

Current 15.32 44.22%
2025
21.49 40.24%
Unlock
2026
15.75 26.71%
Unlock
2027
13.94 11.49%
Unlock
2028
13.55 2.80%
Unlock
2029
13.22 2.44%
Unlock
2030
11.99 9.30%
Unlock

Current Faes Farma SAReg Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BANCO SANTANDER
Locked
Locked
Locked Dec 01 2025
ODDO BHF
Locked
Locked
Locked Nov 05 2025
KUTXABANK INVESTMENT
Locked
Locked
Locked Oct 31 2025
CAIXABANK BPI
Locked
Locked
Locked Oct 15 2025
ODDO BHF
Locked
Locked
Locked Jul 25 2025
BANCO SANTANDER
Locked
Locked
Locked Jul 23 2025
BANCO SANTANDER
Locked
Locked
Locked Jul 10 2025
Analyst Rating Date
Locked
BANCO SANTANDER:
Locked
Locked
Dec 01 2025
Locked
ODDO BHF:
Locked
Locked
Nov 05 2025
Locked
KUTXABANK INVESTMENT:
Locked
Locked
Oct 31 2025
Locked
CAIXABANK BPI:
Locked
Locked
Oct 15 2025
Locked
ODDO BHF:
Locked
Locked
Jul 25 2025
Locked
BANCO SANTANDER:
Locked
Locked
Jul 23 2025
Locked
BANCO SANTANDER:
Locked
Locked
Jul 10 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today